PEPG

PepGen Inc.

6.20 USD

Last updated Dec 11, 23:07 UTC

Yesterday HIGH

$7

Yesterday LOW

$6.42

52w HIGH

$20

52w LOW

$3.72

EPS

-0.98

PE

-6.33

Next Earnings

Mar 21, 2024

Overview News Insider Transactions Government Trades

PepGen Inc. stock is up 60.62% since 30 days ago. The next earnings date is Mar 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 1 December’s closed higher than November.

PepGen Inc. focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

-

Website

pepgen.com

Benzinga Newsdesk

Thu May 11, 2023

PepGen Q1 EPS $(0.69) Beats $(0.79) Estimate; Cash Balance Of $165.4M With Cash Runway Expected Into 2025

PepGen (NASDAQ:PEPG) reported quarterly losses of $(0.69) per share which beat the analyst consensus estimate of $(0.79) by 12.66 percent. This is a 96.36 percent increase over losses of $(18.94) per share from the same
richadhand@benzinga.com

Mon Apr 3, 2023

HC Wainwright & Co. Reiterates Buy on PepGen, Maintains $26 Price Target

HC Wainwright & Co. analyst Andrew Fein reiterates PepGen (NASDAQ:PEPG) with a Buy and maintains $26 price target.
Lisa Levin

Mon Mar 27, 2023

Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.
Lisa Levin

Mon Mar 27, 2023

BioNTech, Coinbase Global, Pharming Group And Other Big Stocks Moving Lower On Monday

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Monday. Here are some big stocks recording losses in today’s session.
Lisa Levin

Fri Mar 24, 2023

Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50.
Benzinga Newsdesk

Fri Mar 24, 2023

Wedbush Maintains Outperform on PepGen, Raises Price Target to $22

Wedbush analyst Laura Chico maintains PepGen (NASDAQ:PEPG) with a Outperform and raises the price target from $17 to $22.
richadhand@benzinga.com

Fri Mar 24, 2023

HC Wainwright & Co. Reiterates Buy on PepGen, Maintains $26 Price Target

HC Wainwright & Co. analyst Andrew Fein reiterates PepGen (NASDAQ:PEPG) with a Buy and maintains $26 price target.
Bill Haddad

Thu Mar 23, 2023

PepGen Cash Position $181.8M As Of Dec. 31
Benzinga Insights

Thu Mar 23, 2023

Earnings Scheduled For March 23, 2023

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter.
Lisa Levin

Fri Jan 20, 2023

Around $12M Bet On This Technology Stock? Check Out These 3 Stocks Insiders Are Buying

Although US stocks closed lower on Thursday, there were a few notable insider trades.

McArthur James G, Director

Thu Nov 30, 2023

PEPG Recent Insider Trades and Stock Chart

1,694 shares bought
Mayer Howard, Director

Fri Nov 10, 2023

PEPG Recent Insider Trades and Stock Chart

22,686 shares awarded